Methotrexate Beneficial for Reducing Pain, Stiffness in Knee Osteoarthritis
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 31, 2024 -- For patients with knee osteoarthritis (KOA), methotrexate added to usual medication is associated with a significant reduction in pain and improvement in stiffness and function at six months, according to a study published online July 30 in the Annals of Internal Medicine.
Sarah R. Kingsbury, Ph.D., from the University of Leeds in the United Kingdom, and colleagues conducted a multicenter randomized, double-blind, placebo-controlled trial to examine symptomatic benefits of methotrexate among 207 patients with symptomatic, radiographic KOA and knee pain. Overall, 155 patients were randomly assigned to once-weekly methotrexate or placebo once weekly over 12 months and continued usual analgesia (77 and 78, respectively). At six months, 66 and 68 patients were followed up.
The researchers observed a decrease in mean knee pain from baseline to six months, from 6.4 to 5.1 and from 6.8 to 6.2 in the methotrexate and placebo groups, respectively. A significant pain reduction of 0.79 numerical rating scale points in favor of methotrexate was seen in the primary intention-to-treat analysis. Significant treatment group differences in favor of methotrexate were also seen for Western Ontario and McMaster Universities Osteoarthritis Index stiffness and function at six months (0.60 and 5.01 points, respectively). A dose-response effect was supported by a treatment adherence analysis.
"Further work is required to understand adequate methotrexate dosing, whether benefits are greater in those with elevated systemic inflammation levels, and to consider cost-effectiveness before introducing this therapy for a potentially large population," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
Depression, Anxiety, Fibromyalgia Common With Rheumatoid Arthritis, Osteoarthritis
WEDNESDAY, July 24, 2024 -- Approximately four in 10 patients with osteoarthritis (OA) or rheumatoid arthritis (RA) have anxiety, depression, or fibromyalgia, according to a study...
Physical Activity Cuts Depression in People With Arthritis-Related Pain
TUESDAY, July 23, 2024 -- Physical activity may be particularly important to manage depression symptoms in people with greater osteoarthritis-related pain, according to a study...
Race, Ethnic Disparities Seen in Age-Adjusted Prevalence of Arthritis
WEDNESDAY, July 17, 2024 -- The age-adjusted prevalence of arthritis varies by race and ethnicity, with higher prevalence seen among American Indian/Alaska Native adults...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.